Non-B DNA-informed mutation burden as a marker of treatment response and outcome in cancer
Q Xu, J Kowalski - British Journal of Cancer, 2024 - nature.com
Background Genomic instability is crucial in tumorigenesis, with Tumour Mutation Burden
(TMB) being a biomarker to indicate therapeutic effectiveness, particularly in …
(TMB) being a biomarker to indicate therapeutic effectiveness, particularly in …
PACMIDS: Patient-Centered, AI-Enabled, Molecular-Informed Data Fabric for Clinical Treatment Decision Support
J Kowalski, Q Xu, M Ylagan… - AI in Precision …, 2024 - liebertpub.com
Introduction: The demand for comprehensive data resources has surged due to
advancements in research aimed at tackling complex questions. Data integration techniques …
advancements in research aimed at tackling complex questions. Data integration techniques …